
Nathaniel Mabe,PharmD,PhD
@nathaniel_mabe
Assistant professor, Purdue MCMP | Interested in epigenetic plasticity in pediatric solid tumors
ID: 1268615022638510080
https://www.mabelabpurdue.com/ 04-06-2020 18:46:14
47 Tweet
251 Followers
325 Following

Our work led by @senspeaks and Sanjukta Das, connecting tumor cell lineage to immunogenic phenotypes in neuroblastoma, is now online in Nature Cancer rdcu.be/cV7ug. These studies highlight the immunogenic potential of the mesenchymal lineage tumors.

Holy cow! Open call for a Researcher position (MSc or PhD, no post-doc experience needed). This will person will be a part of the Pediatric Dependencies Project - a collaboration between Broad Institute, Dana-Farber/Boston Children's and St. Jude Research! Cool, right? talent.stjude.org/careers/jobs/1…

Online today in Cell! Our fab collaboration with Iain Cheeseman lab: image-based screen 5K+ essential genes to build a resource defining the phenotypic consequences of disrupting core cellular processes Broad Institute Whitehead Institute Luke Funk cell.com/cell/fulltext/…

Check out two new publications on Ewing sarcoma and ETV6 in Nature Cell Biology from our lab and Christopher Vakoc. Excited to see them both in press! doi.org/10.1038/s41556…




Purdue Borch MCMP is hiring for Faculty Positions in Translational Neuroscience and Chemical Biology careers.purdue.edu/job-invite/282…



We'll be opening lab doors in May and are recruiting a research technician with a start in May or June. If you are interested in studying pediatric cancer please reach out or apply. careers.purdue.edu/job-invite/302… Purdue Borch MCMP Purdue Institute for Cancer Research Purdue Pharmacy

Today marks the close of the postdoc chapter. I am fortunate to have called the Stegmaier Lab home for the last 5 years. It was a privilege to work alongside so many amazing and talented scientists throughout this journey. Thank you for all the good memories!


New publication by #teamneuroblastoma in the Stegmaier Lab lab in collaboration with the Dent lab at MD Anderson. science.org/doi/10.1126/sc…. Happy to have helped bring this one over the finish line after the work done by Clare Malone, PhD and Allie Forman.

With 3 approved epigenetic drug classes and many more under clinical investigation, epigenetic targets are gaining traction. Here, we take survey of developments and hurdles in targeting the cancer epigenome. Thank you Nature Cancer for the opportunity nature.com/articles/s4301…